## Background: The majority of adult patients who are treated for lymphoblastic disease will either develop recurrent disease or will be refractory to their initial therapy. one option for patients with recurrent/refractory disease is to administer a reinduction regimen that employs a dose-intense
β¦ LIBER β¦
Induction therapy for adults with acute lymphoblastic leukemia
β Scribed by Robert J. Wells
- Book ID
- 107546482
- Publisher
- Current Science Inc.
- Year
- 2006
- Tongue
- English
- Weight
- 66 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1523-3790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A single, high dose of idarubicin combin
β
Mark A. Weiss; Timothy B. Aliff; Martin S. Tallman; Stanley R. Frankel; Matt E.
π
Article
π
2002
π
John Wiley and Sons
π
English
β 79 KB
Induction therapy by frequent administra
β
Takeuchi, J; Kyo, T; Naito, K; Sao, H; Takahashi, M; Miyawaki, S; Kuriyama, K; O
π
Article
π
2002
π
Nature Publishing Group
π
English
β 155 KB
Acute lymphoblastic leukemia in adults
β
Mark R. Litzow
π
Article
π
2000
π
Springer
π
English
β 291 KB
Modern treatment programs for adults wit
β
Farhad Ravandi; Stefan Faderl; Partow Kebriaei; Hagop Kantarjian
π
Article
π
2007
π
Current Science Inc.
π
English
β 157 KB
Successful induction therapy with decita
β
YΓ‘nez, L; BermΓΊdez, A; Richard, C; Bureo, E; Iriondo, A
π
Article
π
2009
π
Nature Publishing Group
π
English
β 75 KB
The biology and therapy of adult acute l
β
Stefan Faderl; Sima Jeha; Hagop M. Kantarjian
π
Article
π
2003
π
John Wiley and Sons
π
English
β 383 KB
## Abstract ## BACKGROUND Much progress has been made in understanding the biology of acute lymphoblastic leukemia (ALL). This has translated into the recognition of several subgroups of ALL and the institution of riskβadapted therapies. New therapies are emerging based on the definition of specif